A detailed history of Private Capital Group, LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Private Capital Group, LLC holds 171 shares of EBS stock, worth $1,419. This represents 0.0% of its overall portfolio holdings.

Number of Shares
171
Previous 179 4.47%
Holding current value
$1,419
Previous $7,000 28.57%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

SELL
$27.42 - $43.63 $219 - $349
-8 Reduced 4.47%
171 $5,000
Q1 2022

Apr 21, 2022

BUY
$36.48 - $52.22 $5,471 - $7,833
150 Added 517.24%
179 $7,000
Q4 2021

Jan 24, 2022

SELL
$33.11 - $55.01 $7,615 - $12,652
-230 Reduced 88.8%
29 $1,000
Q3 2021

Oct 13, 2021

SELL
$50.07 - $66.05 $17,023 - $22,457
-340 Reduced 56.76%
259 $13,000
Q2 2021

Jul 26, 2021

SELL
$56.61 - $80.46 $63,516 - $90,276
-1,122 Reduced 65.19%
599 $38,000
Q1 2021

Apr 12, 2021

SELL
$86.23 - $125.19 $16,297 - $23,660
-189 Reduced 9.9%
1,721 $160,000
Q4 2020

Jan 26, 2021

BUY
$79.17 - $111.47 $15,438 - $21,736
195 Added 11.37%
1,910 $171,000
Q3 2020

Nov 12, 2020

SELL
$81.91 - $134.94 $28,668 - $47,229
-350 Reduced 16.95%
1,715 $177,000
Q2 2020

Aug 13, 2020

SELL
$54.33 - $89.52 $15,810 - $26,050
-291 Reduced 12.35%
2,065 $163,000
Q1 2020

May 07, 2020

SELL
$49.34 - $68.76 $4,637 - $6,463
-94 Reduced 3.84%
2,356 $136,000
Q4 2019

Feb 14, 2020

BUY
$51.21 - $59.06 $15,158 - $17,481
296 Added 13.74%
2,450 $132,000
Q3 2019

Nov 13, 2019

SELL
$40.6 - $57.2 $9,865 - $13,899
-243 Reduced 10.14%
2,154 $113,000
Q2 2019

Aug 15, 2019

BUY
$39.92 - $53.86 $9,540 - $12,872
239 Added 11.08%
2,397 $121,000
Q1 2019

Apr 26, 2019

SELL
$48.23 - $66.16 $4,871 - $6,682
-101 Reduced 4.47%
2,158 $109,000
Q4 2018

Jan 28, 2019

BUY
$55.63 - $73.24 $2,280 - $3,002
41 Added 1.85%
2,259 $134,000
Q3 2018

Oct 31, 2018

SELL
$52.05 - $66.51 $9,316 - $11,905
-179 Reduced 7.47%
2,218 $146,000
Q2 2018

Aug 09, 2018

BUY
$48.33 - $55.64 $31,269 - $35,999
647 Added 36.97%
2,397 $121,000
Q1 2018

May 16, 2018

BUY
$44.44 - $54.39 $74,481 - $91,157
1,676 Added 2264.86%
1,750 $92,000
Q4 2017

May 18, 2018

SELL
$37.77 - $47.75 $5,589 - $7,067
-148 Reduced 66.67%
74 $1,000
Q4 2017

Mar 07, 2018

BUY
$37.77 - $47.75 $8,384 - $10,600
222
222 $6,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $414M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.